InvestSMART

Immutep Limited (ASX: IMM) - Announcements

- Current share price for IMM : $0.023

ASX company news and announcements for Immutep Limited (IMM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immutep Limited (IMM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immutep Limited (IMM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immutep Limited (IMM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$34 Immutep to present TACTI-002 data at German Cancer Congress 4 Feb 2020 8:19AM $0.325 $0.023 fallen by 92.92%
$34 Immutep Activities Report 29 Jan 2020 9:41AM $0.275 $0.023 fallen by 91.64%
$34 Appendix 4C - quarterly 29 Jan 2020 9:02AM $0.275 $0.023 fallen by 91.64%
$34 Immutep Corporate Presentation 10 Jan 2020 9:53AM $0.285 $0.023 fallen by 91.93%
$34 Immutep expands Part C of TACTI-002 due to positive data 9 Jan 2020 8:23AM $0.265 $0.023 fallen by 91.32%
$34 Change in substantial holding 6 Jan 2020 8:18AM $0.260 $0.023 fallen by 91.15%
$34 Change of Director's Interest Notice 2 Jan 2020 8:19PM $0.260 $0.023 fallen by 91.15%
$34 Appendix 3B 2 Jan 2020 4:19PM $0.260 $0.023 fallen by 91.15%
$34 INSIGHT-004 clinical trial update 19 Dec 2019 8:48AM $0.250 $0.023 fallen by 90.80%
$34 Change of Director's Interest Notice - Mr Meyers 9 Dec 2019 4:17PM $0.240 $0.023 fallen by 90.42%
$34 Change of Director's Interest Notice - Dr Howard 9 Dec 2019 4:14PM $0.240 $0.023 fallen by 90.42%
$34 Change of Director's Interest Notice - Mr Voigt 9 Dec 2019 4:14PM $0.240 $0.023 fallen by 90.42%
$34 Appendix 3B 2 Dec 2019 5:46PM $0.250 $0.023 fallen by 90.80%
$34 Immutep Investor Update 22 Nov 2019 9:41AM $0.245 $0.023 fallen by 90.61%
$34 Immutep announces European patent grant for LAG525 antibody 14 Nov 2019 8:21AM $0.280 $0.023 fallen by 91.79%
$34 IMM presents positive interim phase 2 TACTI-002 data at SITC 8 Nov 2019 8:28AM $0.285 $0.023 fallen by 91.93%
$34 Update - Consolidation/Split - IMM 1 Nov 2019 4:14PM $0.028 $0.023 fallen by 17.86%
$34 Results of Annual General Meeting 1 Nov 2019 12:39PM $0.029 $0.023 fallen by 20.69%
$34 2019 AGM CEO Presentation 1 Nov 2019 10:22AM $0.028 $0.023 fallen by 17.86%
$34 2019 AGM Chairman's Address 1 Nov 2019 9:36AM $0.028 $0.023 fallen by 17.86%
$34 Consolidation/Split - IMM 31 Oct 2019 7:00PM $0.028 $0.023 fallen by 17.86%
$34 Operational Update 28 Oct 2019 2:22PM $0.028 $0.023 fallen by 17.86%
$34 Change in substantial holding 24 Oct 2019 8:34AM $0.027 $0.023 fallen by 14.81%
$34 Appendix 4C - quarterly 23 Oct 2019 5:04PM $0.027 $0.023 fallen by 14.81%
$34 Immutep presents positive TACTI-mel melanoma trial data 15 Oct 2019 8:32AM $0.025 $0.023 fallen by 8%

626 - 650 of 798 results

Page 26 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.